Andreoli, Michael T., Michael Pinnolis, Troy Kieser, Jennifer Sun, and Christopher M. Andreoli. 2015. “Feasibility and Efficacy of a Mass Switch from Ranibizumab (Lucentis) to Bevacizumab (Avastin) for Treatment of Neovascular Age-Related Macular Degeneration”. Digital Journal of Ophthalmology 21 (3). Boston, Massachusetts, USA:29-34. https://doi.org/10.5693/djo.01.2015.04.002.